UBAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.545000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.439400E-01
Normal-vs-Stage2
7.379800E-01
Normal-vs-Stage3
2.472400E-01
Normal-vs-Stage4
5.588200E-02
Stage1-vs-Stage2
1.103400E-01
Stage1-vs-Stage3
1.371000E-01
Stage1-vs-Stage4
2.996900E-03
Stage2-vs-Stage3
1.212190E-01
Stage2-vs-Stage4
8.255600E-02
Stage3-vs-Stage4
5.719500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.714800E-01
Normal-vs-AfricanAmerican
9.423800E-01
Normal-vs-Asian
7.668800E-01
Caucasian-vs-AfricanAmerican
5.990800E-01
Caucasian-vs-Asian
9.601600E-01
AfricanAmerican-vs-Asian
6.531000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.303600E-01
Normal-vs-Female
8.083000E-01
Male-vs-Female
4.447400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.640400E-01
Normal-vs-Age(41-60Yrs)
4.675200E-01
Normal-vs-Age(61-80Yrs)
9.188200E-01
Normal-vs-Age(81-100Yrs)
7.264400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.403800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.946400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.048200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.475550E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.840900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.928200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.518600E-01
Normal-vs-Daily Drinker
8.243600E-01
Normal-vs-Weekly Drinker
8.149200E-01
Normal-vs-Occasional Drinker
4.886400E-01
Normal-vs-Social Drinker
4.491200E-01
Non Drinker-vs-Daily Drinker
2.535200E-01
Non Drinker-vs-Weekly Drinker
2.038600E-01
Non Drinker-vs-Occasional Drinker
3.271700E-02
Non Drinker-vs-Social Drinker
3.773800E-02
Daily Drinker-vs-Weekly Drinker
8.257400E-01
Daily Drinker-vs-Occasional Drinker
4.874400E-01
Daily Drinker-vs-Social Drinker
8.490000E-01
Weekly Drinker-vs-Occasional Drinker
2.987000E-01
Weekly Drinker-vs-Social Drinker
5.442200E-01
Occasional Drinker-vs-Social Drinker
4.542000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.322200E-01
Normal-vs-Grade 2
1.333010E-01
Normal-vs-Grade 3
2.264800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.539670E-02
Grade 1-vs-Grade 3
4.806200E-02
Grade 1-vs-Grade 4
7.322200E-01
Grade 2-vs-Grade 3
8.454600E-01
Grade 2-vs-Grade 4
1.333010E-01
Grade 3-vs-Grade 4
2.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.255400E-01
Normal-vs-NonDiabetic
7.309600E-01
Diabetic-vs-NonDiabetic
4.066200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.523600E-01
Normal-vs-NoPancreatitis
7.905200E-01
Pancreatitis-vs-NoPancreatitis
7.627600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.146400E-01
Normal-vs-N1
6.787800E-01
N0-vs-N1
1.445440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.723200E-01
Normal-vs-TP53-NonMutant
9.836000E-01
TP53-Mutant-vs-TP53-NonMutant
6.729900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
